PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27121513-8	2016	This review describes the mechanisms by which PI3-K/AKT pathway causes radioresistance and the role of HIV protease inhibitors especially nelfinavir as a potential candidate drug to target the AKT pathway for overcoming radioresistance and its use in various clinical trials for different malignancies.	Nelfinavir	138-148	AKT serine/threonine kinase 1	Rattus norvegicus	193-196	
15269981-5	2004	RESULT: Nelfinavir decreased insulin stimulated phosphorylation of IRS-2 and Akt-Thr(308) in a dose-dependent manner; for 10 micromol/L of nelfinavir, the decrease was 52% and 55%, respectively.	Nelfinavir	8-18	AKT serine/threonine kinase 1	Rattus norvegicus	77-80	
15269981-5	2004	RESULT: Nelfinavir decreased insulin stimulated phosphorylation of IRS-2 and Akt-Thr(308) in a dose-dependent manner; for 10 micromol/L of nelfinavir, the decrease was 52% and 55%, respectively.	Nelfinavir	139-149	AKT serine/threonine kinase 1	Rattus norvegicus	77-80